ClinicalTrials.Veeva

Menu

Influence of Opioid Use on the Effects of Spinal Manipulative Therapy for Low Back Pain

Utah System of Higher Education (USHE) logo

Utah System of Higher Education (USHE)

Status

Terminated

Conditions

Opioid Use
Low Back Pain

Treatments

Behavioral: SMT
Behavioral: Mobilizing Exercises
Behavioral: Activation Exercises
Behavioral: Extended SMT

Study type

Interventional

Funder types

Other

Identifiers

NCT03749564
59006084

Details and patient eligibility

About

This project is a supplement to the parent project (UH3AT009293) entitled "Optimization of Spinal Manipulative Therapy (SMT) Protocols". The goal of the parent project is to examine strategies to optimize SMT treatment protocols for patients with low back pain (LBP). The parent project is investigating mechanistic and clinical outcomes of SMT combined with varying co-interventions. This supplemental project will examine the impact of opioid use on these outcomes.

Full description

This supplement expands the parent research project to include three additional Aims and the recruitment of the 70 additional participants. The additional participants will undergo the same assessment and intervention procedures outlined in the parent project to permit leveraging the full cohort to evaluate the supplemental Aims.

The overall objective is to examine the impact of opioid use on patient-centered and mechanistic outcomes related to SMT and explore the impact on SMT followed by various co-interventions. The goal of this research is to better tailor SMT protocols to optimize outcomes for patients with LBP who are opioid users and facilitate efforts to reduce reliance on opioid pain management among those with LBP. Accomplishing this goal will facilitate future research evaluating the efficacy of non-pharmacologic alternative pain management strategies for individuals with LBP.

Specific Aims to be addressed through this supplement are:

  1. Compare baseline psychological, mechanistic and LBP-related characteristics between sub-groups of participants with LBP based on opioid use.
  2. Examine the association of opioid use with changes in mechanistic and patient-centered outcomes between a baseline assessment and subsequent assessment after 1-week and completion of a 2-session SMT intervention protocol.
  3. Explore the moderating effects of opioid use on mechanistic and patient-centered outcomes obtained 4 weeks following SMT intervention with varied co-intervention components.

Examining these aims as a supplement to the parent project will allow evaluation of whether or not opioid use impacts short-term mechanistic and patient-centered outcomes of SMT (Aim 2), and will explore if the longer-term effects of the three co-interventions differ between opioid users and non-users. (Aim 3). This research will also compare baseline characteristics between participants who are or are not opioid users (Aim 1).

Enrollment

7 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pain between the 12th rib and buttocks with or without symptoms into one or both legs, which, in the opinion of the examiner, originate from the lumbar region.
  • Age 18 - 60 years
  • Oswestry disability score > 20%
  • Self-reported

Exclusion criteria

  • Prior surgery to the lumbosacral spine
  • Currently pregnant
  • Currently receiving mind-body or exercise treatment for LBP from a healthcare provider (e.g., chiropractic, physical therapy, massage therapy, etc.)
  • Neurogenic signs including any of the following: positive ipsi- or contra-lateral straight leg raise test; reflex, sensory, or strength deficit in a pattern consistent with lumbar nerve root compression

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Double Blind

7 participants in 8 patient groups

SMT Only
Experimental group
Description:
All patients receive 2 SMT sessions in the first week.
Treatment:
Behavioral: SMT
SMT extended
Experimental group
Description:
All patients receive 2 SMT sessions in the first week. This arm also involves 6 additional SMT sessions. Each SMT session is conducted as described previously.
Treatment:
Behavioral: SMT
Behavioral: Extended SMT
SMT with Activation Exercises
Experimental group
Description:
All patients receive 2 SMT sessions in the first week. This arm receives 6 additional sessions of activation exercises.
Treatment:
Behavioral: Activation Exercises
Behavioral: SMT
SMT with Mobilizing Exercises
Experimental group
Description:
All patients receive 2 SMT sessions in the first week. This arm involves 6 additional sessions of mobilizing exercise.
Treatment:
Behavioral: Mobilizing Exercises
Behavioral: SMT
SMT with Mobilizing and Activation Exercises
Experimental group
Description:
All patients receive 2 SMT sessions in the first week. This arm involves 6 additions sessions including both activation and mobilizing exercises.
Treatment:
Behavioral: Mobilizing Exercises
Behavioral: Activation Exercises
Behavioral: SMT
SMT extended with Mobilizing Exercises
Experimental group
Description:
All patients receive 2 SMT sessions in the first week. This arm includes 6 additional sessions including both SMT and mobilizing exercises.
Treatment:
Behavioral: Mobilizing Exercises
Behavioral: SMT
Behavioral: Extended SMT
SMT extended with Activation Exercises
Experimental group
Description:
All patients receive 2 SMT sessions in the first week. This arm includes 6 additional sessions including both SMT and activation exercises.
Treatment:
Behavioral: Activation Exercises
Behavioral: SMT
Behavioral: Extended SMT
SMT extended with Mobilizing and Activation Exercises
Experimental group
Description:
All patients receive 2 SMT sessions in the first week. This arm includes 6 additional sessions including SMT, activation and mobilizing exercises.
Treatment:
Behavioral: Mobilizing Exercises
Behavioral: Activation Exercises
Behavioral: SMT
Behavioral: Extended SMT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems